8123 T. Kawabe
- 1465
- 00.00%
T. Kawabe News
T. Kawabe: Corporate Governance Report as of July 5, 2024.
T. Kawabe: Interim report
T. Kawabe: Internal Control Report - 79th Term (2023/04/01 - 2024/03/31)
T. Kawabe: Confirmatory letter.
T. Kawabe: Securities Report - 79th Fiscal Year (April 1, 2023 - March 31, 2024)
T. Kawabe: Progress report based on the plan for compliance with listing maintenance standards.
T. Kawabe: Regarding matters related to dominant shareholders.
T. Kawabe: Notice of Convocation of the 79th Regular Shareholders' Meeting
T KAWABE: Notice regarding a decrease in the amount of capital (capital reduction)
T KAWABE: Notice regarding differences between individual management results for the fiscal year ending 2024/3 and actual values for the previous fiscal year
T KAWABE: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
T KAWABE: Notice regarding the re-revision (upward revision) of the full-year consolidated earnings forecast
T. Kawabe: Notice Concerning Organizational Reforms and Personnel Changes (Additional)
T. Kawabe: Notice regarding organizational reforms and personnel changes
Kawabe: Notice regarding revisions to the full-year consolidated earnings forecast and dividend forecast (dividend increase and 100th anniversary dividend)
Kawabe: Notice regarding financial results of unlisted parent companies, etc.
Kawabe: Confirmation
Kawabe: Quarterly Report - Third quarter of the 79th term (2023/10/01 - 2023/12/31)
T. Kawabe: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
T. Kawabe: Notice regarding additional investment in DR.C Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
